EyePoint, Inc. EYPT
- DURAVYU — Wet Age-Related Macular Degeneration Phase 3
- DURAVYU — Diabetic Macular Edema Phase 3
JAK1 (2 companies · 3 programs)
Companies with an active program directed at JAK1.
Aclaris Therapeutics ACRS
- lepzacitinib — Atopic Dermatitis